Form 8-K Filing Summary

Rockwell Medical, Inc. held its 2026 Annual Meeting of Stockholders on June 12, 2026. The stockholders voted on four proposals: 1. Election of two Class II directors, Joseph Dawson and Joan Lau, Ph.D., for a three-year term. Both were elected. 2. Advisory vote on the compensation of named executive officers, which was approved. 3. Ratification of EisnerAmper LLP as the independent registered public accounting firm for 2026, which was ratified. 4. Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split of the company's common stock, which was approved. The filing was signed by Mark Strobeck, Chief Executive Officer, on June 15, 2026.